Accessibility / Report Error
Revista Brasileira de Hematologia e Hemoterapia, Volume: 39, Issue: 1, Published: 2017
  • Paradoxes of hematology: When the old disappears and the new does not arrive Editorial

    Maiolino, Angelo; Simões, Belinda Pinto; Castro, Claudio Galvão de; Covas, Dimas Tadeu; Fernandes, Gustavo dos Santos; Hamerschlak, Nelson; Fonseca, Teresa Cristina Cardoso; Colturato, Vergilio
  • Secondary myeloid neoplasms: bone marrow cytogenetic and histological features may be relevant to prognosis Original Articles

    Tanizawa, Roberta Sandra da Silva; Zerbini, Maria Claudia Nogueira; Rosenfeld, Ricardo; Kumeda, Cristina Aiko; Azevedo, Raymundo Soares; Siqueira, Sheila Aparecida Coelho; Velloso, Elvira Deolinda Rodrigues Pereira

    Abstract in English:

    Abstract Background: Secondary myeloid neoplasms comprise a group of diseases arising after chemotherapy, radiation, immunosuppressive therapy or from aplastic anemia. Few studies have addressed prognostic factors in these neoplasms. Method: Forty-two patients diagnosed from 1987 to 2008 with secondary myeloid neoplasms were retrospectively evaluated concerning clinical, biochemical, peripheral blood, bone marrow aspirate, biopsy, and immunohistochemistry and cytogenetic features at diagnosis as prognostic factors. The International Prognostic Scoring System was applied. Statistical analysis employed the Kaplan–Meier method, log-rank and Fisher's exact test. Results: Twenty-three patients (54.8%) were male and the median age was 53.5 years (range: 4–88 years) at diagnosis of secondary myeloid neoplasms. Previous diseases included hematologic malignancies, solid tumors, aplastic anemia, autoimmune diseases and conditions requiring solid organ transplantations. One third of patients (33%) were submitted to chemotherapy alone, 2% to radiotherapy, 26% to both modalities and 28% to immunosuppressive agents. Five patients (11.9%) had undergone autologous hematopoietic stem cell transplantation. The median latency between the primary disease and secondary myeloid neoplasms was 85 months (range: 23–221 months). Eight patients were submitted to allogeneic hematopoietic stem cell transplantation to treat secondary myeloid neoplasms. Important changes in bone marrow were detected mainly by biopsy, immunohistochemistry and cytogenetics. The presence of clusters of CD117+ cells and p53+ cells were associated with low survival. p53 was associated to a higher risk according to the International Prognostic Scoring System. High prevalence of clonal abnormalities (84.3%) and thrombocytopenia (78.6%) were independent factors for poor survival. Conclusion: This study demonstrated that cytogenetics, bone marrow biopsy and immunohistochemistry are very important prognostic tools in secondary myeloid neoplasms.
  • Adult T-cell leukemia/lymphoma treatment in Bahia, Brazil Original Articles

    Oliveira, Pedro Dantas; Gomes, Ítala; Souza, Victor Hugo Gomes; Pires, Ernesto Cunha; Arruda, Glória Bomfim; Bittencourt, Achiléa

    Abstract in English:

    Abstract Background: Adult T-cell leukemia/lymphoma is a peripheral disease associated with human T-cell lymphotropic virus type 1. Treatment is carried out according to clinical type with watchful waiting being recommended for less aggressive types. Aggressive adult T-cell leukemia/lymphoma is generally treated with chemotherapy and/or antivirals. The objective of this study was to correlate the survival of patients diagnosed in Bahia, Brazil, with the therapeutic approaches employed and to evaluate what issues existed in their treatment processes. Methods: Eighty-three adult T-cell leukemia/lymphoma patients (26 smoldering, 23 chronic, 16 acute, 13 lymphoma and five primary cutaneous tumoral) with available data were included in this study. Results: Complete response was achieved in seven smoldering patients with symptomatic treatment, in two with chronic disease using antivirals/chemotherapy, in one with acute disease using antivirals and in one lymphoma using the LSG15 regimen [vincristine, cyclophosphamide, doxorubicin, and prednisolone (VCAP); doxorubicin, ranimustine, and prednisolone (AMP); and vindesine, etoposide, carboplatin, and prednisolone (VECP)]. Smoldering patients who received symptomatic treatment presented longer survival. Favorable chronic patients treated with antivirals presented longer survival compared to the unfavorable subtype. However, for the acute form, first-line chemotherapy was better, albeit without significance, than antivirals. Only one of the patients with lymphoma and primary cutaneous tumors responded. Conclusions: Watchful waiting associated with phototherapy represents the best option for smoldering adult T-cell leukemia/lymphoma with survival in Bahia being superior to that described in Japan. There was a trend of better results with zidovudine/interferon-alpha in favorable chronic disease. Excellent results were achieved in the lymphoma type treated with the LSG15 protocol. Patients are diagnosed late probably due to lack of knowledge of adult T-cell leukemia/lymphoma by primary healthcare doctors and a Brazilian treatment protocol needs to be established.
  • A Phase Ib open label, randomized, safety study of SANGUINATE™ in patients with sickle cell anemia Original Articles

    Misra, Hemant; Bainbridge, James; Berryman, John; Abuchowski, Abraham; Galvez, Kenneth Mauricio; Uribe, Luis Fernando; Hernandez, Angel Luis; Sosa, Nestor Rodolfo

    Abstract in English:

    Abstract Background: Treatment of sickle cell anemia is a challenging task and despite the well understood genetic and biochemical pathway of sickle hemoglobin, current therapy continues to be limited to the symptomatic treatment of pain, supplemental oxygen, antibiotics, red blood cell transfusions and hydroxyurea. SANGUINATE is a carbon monoxide releasing molecule and oxygen transfer agent under clinical development for the treatment of sickle cell anemia and comorbidities. Methods: An open-label randomized Phase Ib study was performed in adult sickle cell anemia patients. Two dose levels of SANGUINATE were compared to hydroxyurea in 24 homozygotes for Hb SS. Twelve subjects received either a low dose (160 mg/kg) of SANGUINATE or 15 mg/kg hydroxyurea. Another 12 subjects received either a high dose (320 mg/kg) of SANGUINATE or 15 mg/kg hydroxyurea. The primary endpoint was the safety of SANGUINATE versus hydroxyurea in sickle cell anemia patients. Secondary endpoints included determination of the plasma pharmacokinetics and assessment of hematologic measurements. Results: Musculoskeletal related adverse events were the most common. Transient troponin I levels increased in three patients, one of whom had an increase in tricuspid regurgitant velocity; however, no clinical signs were noted. Following an assessment of vital signs, tricuspid regurgitant velocity, electrocardiogram, serum biochemistry, hematology, urinalysis, and analysis of reported adverse events, SANGUINATE was found to be safe in stable sickle cell anemia patients. Conclusions: The clinical trial met its primary objective of demonstrating an acceptable safety profile for SANGUINATE in patients with sickle cell anemia. This trial established the safety of SANGUINATE at both dose levels and permitted its advance to Phase II trials.
  • Cholelithiasis and its complications in sickle cell disease in a university hospital Original Articles

    Martins, Raquel Alves; Soares, Renato Santos; Vito, Fernanda Bernadelli De; Barbosa, Valdirene de Fátima; Silva, Sheila Soares; Moraes-Souza, Helio; Martins, Paulo Roberto Juliano

    Abstract in English:

    Abstract Introduction: The clinical manifestations of sickle cell disease are related to the polymerization of hemoglobin S. The chronic hemolysis caused by this condition often causes the formation of gallstones that can migrate and block the common bile duct leading to acute abdomen. Objective: This study aimed to evaluate the profile of patients with sickle cell disease and cholelithiasis. Methods: Patients with sickle cell disease were separated into groups according to the presence or absence of cholelithiasis. Socioepidemiological and clinical characteristics, such as gender, age, use of hydroxyurea and the presence of other hemoglobinopathies were researched in the medical records of patients. Results: A hundred and seven patients with sickle cell anemia were treated at the institution. Of these, 27 (25.2%) had cholelithiasis. The presence of cholelithiasis was higher in the 11–29 age group than in younger than 11 years and over 29 years. No association was found for the presence of cholelithiasis with gender, use of hydroxyurea or type of hemoglobinopathy (hemoglobin SS, hemoglobin SC or sickle beta-thalassemia). Sixteen of the patients had to be submitted to cholecystectomy with 14 of the surgeries being performed by laparoscopy. Complications were observed in three patients and one patient died for reasons unrelated to the surgery. Conclusion: A quarter of patients with sickle cell disease had gallstones, more commonly in the 11- to 29-year age range. Patients should be monitored from childhood to prevent cholelithiasis with preoperative, intra-operative and postoperative care being crucial to reduce the risk of complications in these patients.
  • Comprehensive neuropsychological evaluation of children and adolescents with sickle cell anemia: a hospital-based sample Original Articles

    Nunes, Samantha; Argollo, Nayara; Mota, Marivania; Vieira, Camilo; Sena, Eduardo Pondé de

    Abstract in English:

    Abstract Background: Individuals with sickle cell anemia may suffer symptomatic or silent cerebral infarcts leading to neurocognitive complications. This study investigated the cognitive and intellectual performance of children and adolescents with sickle cell anemia. Methods: The socioeconomic status, clinical aspects and behavioral profile of 15 young individuals with sickle cell anemia were evaluated. The Wechsler Intelligence Scale for Children, the Developmental Neuropsychological Assessment Test, and the Child Behavior Checklist were applied. Results: Participants with a history of stroke had lower intelligence quotient (IQ) scores. Alterations were found in attention and executive functioning, language, verbal and visual memory, visuospatial processing and sensorimotor skills. These alterations were found both in the children and adolescents who had had a cerebral infarction and in those who apparently had not. In the majority of cases, there were learning difficulties, a history of repeating school years and a need for specialist educational support. The most common additional diagnoses in accordance with the Diagnostic and Statistical Manual of Mental Disorders IV were depressive disorder, anxiety disorder and somatic disorder, as well as conditions associated with physical and psychosocial repercussions of sickle cell anemia. Conclusion: As sickle cell anemia is considered a progressive cerebral vasculopathy, it is a potential risk factor for neurocognitive and psychosocial development. Therefore, periodic neuropsychological and behavioral evaluations of children and adolescents with sickle cell anemia may represent a useful measure to reduce long-term biopsychosocial repercussions.
  • Clinical and laboratory profile of patients with sickle cell anemia Original Articles

    Sant'Ana, Phelipe Gabriel dos Santos; Araujo, Ariane Moreira; Pimenta, Cynthia Teixeira; Bezerra, Mário Lúcio Pacheco Ker; Borges, Sílvio Pereira; Martins, Viviana; Dias, Janaina Sousa; Lopes, Aline de Freitas; Rios, Danyelle Romana Alves; Pinheiro, Melina de Barros

    Abstract in English:

    Abstract Objective: This study aimed to describe and analyze clinical and laboratory characteristics of patients with sickle cell anemia treated at the Hemominas Foundation, in Divinópolis, Brazil. Furthermore, this study aimed to compare the clinical and laboratory outcomes of the group of patients treated with hydroxyurea with those patients that were not treated with hydroxyurea. Methods: Clinical and laboratorial data were obtained by analyzing medical records of patients with sickle cell anemia. Results: Data from the medical records of 50 patients were analyzed. Most of the patients were female (56%), aged between 20 and 29 years old. Infections, transfusions, cholecystectomy, splenectomy and systemic arterial hypertension were the most common clinical adverse events of the patients. The most frequent cause of hospitalization was painful crisis. The majority of patients had reduced values of hemoglobin and hematocrit (8.55 ± 1.33 g/dL and 25.7 ± 4.4%, respectively) and increased fetal hemoglobin levels (12 ± 7%). None of the clinical variables was statistically significant on comparing the two groups of patients. Among hematological variables only hemoglobin and hematocrit levels were statistically different between patients treated with hydroxyurea and untreated patients (p-value = 0.005 and p-value = 0.001, respectively). Conclusion: Sickle cell anemia requires treatment and follow-up by a multiprofessional team. A current therapeutic option is hydroxyurea. This drug reduces complications and improves laboratorial parameters of patients. In this study, the use of the drug increased the hemoglobin and hematocrit levels of patients.
  • Molecular and hematologic relapses in adult patients with acute promyelocytic leukemia: a cohort study Original Articles

    Azevedo, Ilana de França; Magalhães, Michelline Gomes; Souto, Fernanda Ribeiro; Neves, Washington Batista das; Melo, Fárida Coeli de Barros Correia; Rego, Eduardo Magalhães; Melo, Raul Antônio Morais

    Abstract in English:

    Abstract Objective: To evaluate factors predictive for relapse in a cohort of adult patients with acute promyelocytic leukemia monitored by molecular methods during consolidation and during at least one month of maintenance therapy. Methods: The charts and laboratory data of 65 adult patients with acute promyelocytic leukemia treated according to the International Consortium on Acute Promyelocytic Leukemia 2006 protocol were reviewed. The identification of the promyelocytic leukemia-retinoic acid receptor-alpha gene rearrangement at diagnosis, post-induction, post-consolidation and during maintenance treatment was performed by qualitative and quantitative reverse transcription polymerase chain reaction. Results: Eighty-nine patients were diagnosed with acute promyelocytic leukemia over a seven-year period and of these 65 were eligible for treatment with the protocol. Among the 45 patients who received consolidation and maintenance treatment, six (13%) relapsed, three of whom presented hematologic and three presented molecular relapse. The first relapses occurred at a median of 39 months. Relapsed patients were from all risk groups (low, intermediate and high) and both morphological types (M3 and M3variant) were found. Three of these patients are alive and in molecular remission after salvage treatment. There were no statistically significant differences regarding gender, age, risk group, morphology, promyelocytic leukemia breakpoint cluster region, use of all-trans retinoic acid, development of differentiation syndrome and number of days to complete remission between the patients who relapsed and those who did not. Conclusion: Our results reinforce the importance of prolonged monitoring of acute promyelocytic leukemia patients using molecular methods to detect relapse early.
  • Mortality by sickle cell disease in Brazil Review Article

    Arduini, Giovanna Abadia Oliveira; Rodrigues, Letícia Pinto; Marqui, Alessandra Bernadete Trovó de

    Abstract in English:

    Abstract This work aimed to characterize mortality by sickle cell disease in Brazil. The MEDLINE electronic database was searched using the terms ‘mortality' and ‘sickle cell disease' and ‘Brazil' for articles published in the last five years aiming to provide a current analysis of the subject in question. Eight studies on mortality by sickle cell disease were carried out in the Brazilian states of Maranhão, Bahia, Minas Gerais, Rio de Janeiro and Mato Grosso do Sul. The majority of the deaths occurred in patients with sickle cell anemia, which is the most common genotype and causes the most severe clinical manifestation of the disease. In summary, there are few published studies on mortality related to sickle cell disease in Brazil, and most are from the state of Minas Gerais. This study emphasizes the importance of developing more studies on sickle cell disease mortality, so that it may be possible to profile gene carriers and give health professionals more data to strategize the delivery of more effective assistance to these individuals. Despite the early diagnosis of sickle cell disease by the Neonatal Screening Program and the use of preventive and therapeutic measures (penicillin, immunization and hydroxyurea), mortality by sickle cell disease on the world stage is still significant.
  • Myelodysplasia and acute myeloid leukemia fifteen years after high-dose cyclophosphamide in a child with severe aplastic anemia Case Reports

    Jaime-Pérez, José Carlos; Guerra-Leal, Liliana Nataly; Cantú-Rodríguez, Olga Graciela; Gómez-Almaguer, David
  • Detection of Human Adenovirus (species-C, -D and -F) in an allogeneic stem cell transplantation recipient: a case report Case Reports

    Santos, Hugo César Pereira; Borges, Francielly Pinheiro da Silva; Arantes, Adriano de Moraes; Souza, Menira
  • First observation of Hb Ullevaal [β78(EF2) Leu>Val] in Turkey Case Reports

    Hocaoglu-Emre, F. Sinem; Yenmis, Guven; Yakicier, Cengiz
  • Plasma cell leukemia with t(11;14)(q13;q32) simulating lymphoplasmacytic lymphoma – a diagnostic challenge solved by flow cytometry Case Reports

    Loureiro, Aleyde Diniz; Gonçalves, Matheus Vescovi; Ikoma, Maura Rosário Valério; Silva, Maria Regina Regis; Colleoni, Gisele Wally Braga; Chauffaille, Maria de Lourdes; Yamamoto, Mihoko
  • Cutaneous granulomatous reaction as the first manifestation of Hodgkin's lymphoma Case Reports

    Moreira, Catarina; Rios, Elisabete; Baudrier, Teresa; Azevedo, Filomena
  • Mantle cell lymphoma presenting as multiple lymphomatous polyposis of the gastrointestinal tract Case Reports

    Martins, Cláudio; Teixeira, Cristina; Gamito, Élia; Oliveira, Ana Paula
  • Isolated skin relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplant Case Reports

    Ueda, Masumi; Silva, Carlos; Baer, Linda; Caimi, Paolo F.; Cooper, Kevin; Honda, Kord; Lima, Marcos de
  • A combination of the -α3.7 and --MEDII alleles causing hemoglobin H disease in a Brazilian patient Case Reports

    Ferreira, Roberta Dorta; Mota, Natália de Oliveira; Kimura, Elza Myiuki; Pedroso, Gisele Audrei; Sonati, Maria de Fatima
  • Hemophilic pseudotumor – a rare complication Images In Clinical Hematology

    Duarte, Márcio Luís; Duarte, Élcio Roberto; Solorzano, Edgard Brasil
  • Administration of all-trans retinoic acid through enteral tubes in acute promyelocytic leukemia: the handling of cytotoxic agents and clinical benefits Letters To The Editor

    Okumura, Lucas Miyake; Baruel Okumura, Patrícia Carvalho; Veroneze, Cleni
  • Primary breast lymphoma: a case report Letters To The Editor

    Herráez-Albendea, María Mar; Jarilla-Fernández, María Castillo; Jiménez-Burgos, Francisco Javier
  • Red cell autoantibody mimicking anti-C specificity: a rare manifestation Letters To The Editor

    Subramaniyan, Rajeswari; Veerasamy, Mangalakumar
  • Erratum to "Diagnosis and treatment of chronic lymphocytic leukemia: Recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia" [Rev Bras Hematol Hemoter. 2016;38(4):346–357] Erratum

Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular R. Dr. Diogo de Faria, 775 cj 114, 04037-002 São Paulo/SP/Brasil, Tel. (55 11) 2369-7767/2338-6764 - São Paulo - SP - Brazil
E-mail: secretaria@rbhh.org